Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             131 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: Implications for therapy of cognitive dysfunction in schizophrenia McLean, Samantha L.
 2011
 21 Supplement 2 p. 333-343
11 p.
 artikel
2 Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD Biederman, Joseph
 2011
 21 Supplement 2 p. 508-515
8 p.
 artikel
3 A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial Mathew, Sanjay J.
 2011
 21 Supplement 2 p. 221-229
9 p.
 artikel
4 Calendar of Events 2011
 21 Supplement 2 p. I-
1 p.
 artikel
5 C.04.02 Antipsychotic therapy in bipolar disorder: improving long-term outcomes Young, A.
 2011
 21 Supplement 2 p. S626-
1 p.
 artikel
6 C.09.04 Are we doing enough when assessing the effectiveness of our patient's treatment? Falkai, P.
 2011
 21 Supplement 2 p. S632-S633
2 p.
 artikel
7 C.13.03 Clinical prospects: interpretation of key evidence Lieberman, J.A.
 2011
 21 Supplement 2 p. S637-S638
2 p.
 artikel
8 Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression Dawson, Neil
 2011
 21 Supplement 2 p. 117-128
12 p.
 artikel
9 C.09.01 How can we help our patients with schizophrenia adhere to their medication? Emsley, R.
 2011
 21 Supplement 2 p. S631-
1 p.
 artikel
10 Contents 2011
 21 Supplement 2 p. OBC-
1 p.
 artikel
11 Density of striatal D2 receptors in untreated first-episode psychosis: An I123-IBZM SPECT study Corripio, Iluminada
 2011
 21 Supplement 2 p. 861-866
6 p.
 artikel
12 Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: Any relation to overexpression of central GABAA receptor beta2 subunits? Verleye, Marc
 2011
 21 Supplement 2 p. 457-470
14 p.
 artikel
13 ECNP Announcement:Call for Breaking News 2011
 21 Supplement 2 p. II-
1 p.
 artikel
14 ECNP Announcement: ECNP Members Benefits 2011
 21 Supplement 2 p. II-
1 p.
 artikel
15 ECNP Calendar of Events 2011
 21 Supplement 2 p. I-
1 p.
 artikel
16 ECNP Calendar of Events 2011
 21 Supplement 2 p. I-
1 p.
 artikel
17 Editorial Board 2011
 21 Supplement 2 p. i-
1 p.
 artikel
18 Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons Fraguas, David
 2011
 21 Supplement 2 p. 621-645
25 p.
 artikel
19 Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality Lazary, Judit
 2011
 21 Supplement 2 p. 63-70
8 p.
 artikel
20 Erk activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: Modulation by mk-801 Bertotto, María Eugenia
 2011
 21 Supplement 2 p. 892-904
13 p.
 artikel
21 Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice Dhir, Ashish
 2011
 21 Supplement 2 p. 705-714
10 p.
 artikel
22 In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors Gronier, Benjamin
 2011
 21 Supplement 2 p. 192-204
13 p.
 artikel
23 ISCTM: Implementing phase 2 dose finding adaptive clinical trials Parke, Tom
 2011
 21 Supplement 2 p. 167-174
8 p.
 artikel
24 NewMood: A productive European model of collaboration for translational research in depression Deakin, J.F.W.
 2011
 21 Supplement 2 p. 1-2
2 p.
 artikel
25 Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene–environment model of depression Piubelli, Chiara
 2011
 21 Supplement 2 p. 545-562
18 p.
 artikel
26 P.3.a.003 Abnormal local and long-range functional connectivity in schizophrenia during ultimatum game Yang-Tae, K.
 2011
 21 Supplement 2 p. S454-S455
2 p.
 artikel
27 P.1.a.003 A possible association between panic disorder and the ghrelin gene Annerbrink, K.
 2011
 21 Supplement 2 p. S238-
1 p.
 artikel
28 P.1.a.018 Association analysis of glucocorticoid receptor gene and the muscarinic cholinergic 2 receptor gene in suicidal behaviour Zainullina, A.
 2011
 21 Supplement 2 p. S247-
1 p.
 artikel
29 P.3.a.020 Correlation between the Personal and Social Performance (PSP) scale and the PANSS scale in patients with schizophrenia in Greece Jelastopulu, E.
 2011
 21 Supplement 2 p. S465-
1 p.
 artikel
30 P.6.a.003 Effect of cue-exposure based training in alcoholics on fMRI cue-reactivity Kiefer, F.
 2011
 21 Supplement 2 p. S561-
1 p.
 artikel
31 P.4.009 Afobazol as inhibitor of NRH: quinone reductase 2 enzyme Kadnikov, I.
 2011
 21 Supplement 2 p. S149-S150
2 p.
 artikel
32 P.1.a.020 GNB 3 825TT genotype: older age at onset in major depressive disorders? Gressier, F.
 2011
 21 Supplement 2 p. S248-
1 p.
 artikel
33 P.8.a.010 Impulsivity and sensation-seeking in a sample of Spanish outpatients with anorexia and bulimia nervosa Tajes-Alonso, M.
 2011
 21 Supplement 2 p. S616-
1 p.
 artikel
34 P.1.a.006 LRRK 2-linked Parkinson's disease: genetic and biochemical studies Pchelina, S.
 2011
 21 Supplement 2 p. S240-
1 p.
 artikel
35 P.2.a.011 Major depressive episode characteristics according to the number of prior episodes: baseline analysis of the REPONSE cohort study Llorca, P.M.
 2011
 21 Supplement 2 p. S360-
1 p.
 artikel
36 P.4.a.002 Medication and cognitive-behavioural therapy in the treatment of patients with panic disorder Kolar, D.
 2011
 21 Supplement 2 p. S526-
1 p.
 artikel
37 P.5.a.004 Risk factors in Alzheimer's dementia Baidac, G.M.
 2011
 21 Supplement 2 p. S547-
1 p.
 artikel
38 P.8.a.013 The challenge of subject selection in clinical trials Detke, M.
 2011
 21 Supplement 2 p. S618-
1 p.
 artikel
39 P.5.a.001 Treatment of Alzheimer's disease: rationale for combination therapy with galantamine and memantine Zarra, J.
 2011
 21 Supplement 2 p. S545-
1 p.
 artikel
40 P.4.010 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy Koychev, I.
 2011
 21 Supplement 2 p. S86-S87
2 p.
 artikel
41 P.5.b.003 ABCG 2 gene polymorphism in Alzheimer's disease Feher, A.
 2011
 21 Supplement 2 p. S549-S550
2 p.
 artikel
42 P.4.b.008 Aberrant fronto-cingulate activation in obsessive-compulsive disorder is related to task complexity in a working memory task Wagner, G.
 2011
 21 Supplement 2 p. S536-S537
2 p.
 artikel
43 P.2.b.001 Anhedonia induced by constant light in rats is reversed by imipramine treatment and prevented by neonatal exposure to constant light Martynhak, B.J.
 2011
 21 Supplement 2 p. S368-
1 p.
 artikel
44 P.6.b.009 Deletion of cannabinoid receptor 2 increased ethanol abuse vulnerability associated to alterations in m-opioid receptor gene expression in mice Ortega-Alvaro, A.
 2011
 21 Supplement 2 p. S572-
1 p.
 artikel
45 P.2.b.014 Modulation of 5-HT2A and 5-HT2C receptor expression levels by fluoxetine in a genetic mice model of depression Björk, K.
 2011
 21 Supplement 2 p. S375-S376
2 p.
 artikel
46 P.1.b.005 Oxytocin and psychometric aspects in diabetes mellitus type 2 Kontoangelos, K.
 2011
 21 Supplement 2 p. S252-
1 p.
 artikel
47 P.2.b.004 Prenatal stress and/or chronic mild stress in adolescence influence serotonergic system of the the rat in a sex-specific manner Leibold, N.K.
 2011
 21 Supplement 2 p. S370-
1 p.
 artikel
48 P.6.b.002 Social interactions affect the ethanol preference forming in rats Egorov, A.Y.
 2011
 21 Supplement 2 p. S568-S569
2 p.
 artikel
49 P.6.b.005 The exposure to alcohol and drinking problems of female office workers Lee, H.
 2011
 21 Supplement 2 p. S570-
1 p.
 artikel
50 P.3.c.027 Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study Lee, J.G.
 2011
 21 Supplement 2 p. S483-S484
2 p.
 artikel
51 P.2.c.002 Agomelatine versus selective serotoninergic reuptake inhibitors in major depressive disorder and comorbid diabetes mellitus Vasile, D.
 2011
 21 Supplement 2 p. S383-S384
2 p.
 artikel
52 P.1.c.050 Autologous bone marrow mononuclear cell therapy in MPTP-lesioned rats Capitelli, C.S.
 2011
 21 Supplement 2 p. S281-S282
2 p.
 artikel
53 P.1.c.016 Awakening properties of newly discovered highly selective H3 receptor antagonists in rats Beeské, S.
 2011
 21 Supplement 2 p. S262-
1 p.
 artikel
54 P.1.c.033 Behavioural and biochemical evaluation of the anti-dyskinetic potential of sarizotan, a 5-HT1A agonist, in 6-ODHA lesioned rats Schintu, N.
 2011
 21 Supplement 2 p. S272-
1 p.
 artikel
55 P.3.c.010 Combination of clozapine and escitalopram in treatment of negative symptoms in residual schizophrenia Zivkovic, N.
 2011
 21 Supplement 2 p. S473-
1 p.
 artikel
56 P.3.c.054 Crossover comparison of serum glycemia variability of intramuscular forms of antipsychotics: aripiprazole, olanzapine and ziprasidone Loza, B.
 2011
 21 Supplement 2 p. S499-S500
2 p.
 artikel
57 P.1.c.047 Dopamine and serotonin turnover in the rat fetus brain after prenatal noise stress exposure Bairamov, A.A.
 2011
 21 Supplement 2 p. S280-
1 p.
 artikel
58 P.3.c.051 Effects of clozapine on smoking in patients with serious mental illness Ntounas, P.
 2011
 21 Supplement 2 p. S498-
1 p.
 artikel
59 P.6.c.005 Endocannabinoid involvement in brain reward processing in nicotine addiction van Hell, H.H.
 2011
 21 Supplement 2 p. S578-
1 p.
 artikel
60 P.2.c.019 Galactorrhea induced by clomipramine: a case report Ertekin, B. Aslantas
 2011
 21 Supplement 2 p. S393-S394
2 p.
 artikel
61 P.2.c.027 Inverse correlation between plasma levels of the endocannabinoid, 2-arachidonylglycerol, and severity of symptoms in patients with major depression Xenos, D.
 2011
 21 Supplement 2 p. S398-
1 p.
 artikel
62 P.3.002 Clebopride, an antagonist of dopamine type 2 receptors, in low doses improves learning with positive reinforcement Malyshev, A.V.
 2011
 21 Supplement 2 p. S142-S143
2 p.
 artikel
63 P.1.c.006 Neurochemical and behavioural effects of acute administration of pioglitazone in the MPTP model of Parkinson's disease Barbiero, J.
 2011
 21 Supplement 2 p. S256-
1 p.
 artikel
64 P.1.c.064 Neuroprotective and anti-ischemic effects of ropren in ischemia of the brain in rats Shabanov, P.D.
 2011
 21 Supplement 2 p. S290-
1 p.
 artikel
65 P.3.c.013 Pharmacokinetic study of dose correspondence between oral risperidone and paliperidone in patients with schizophrenia Lee, S.
 2011
 21 Supplement 2 p. S475-
1 p.
 artikel
66 P.3.c.041 Pharmacologic management of psychosis in elderly patients with dementia Szalontay, A.S.
 2011
 21 Supplement 2 p. S492-
1 p.
 artikel
67 P.5.c.004 Psychiatric manifestation of a mild form of limbic encephalitis in a 71 year old patient Stein, P.
 2011
 21 Supplement 2 p. S552-S553
2 p.
 artikel
68 P.1.c.019 The effect of lithium on oxidant–antioxidant balance in vitro and in neuronal cell cultures Gawlik, O.
 2011
 21 Supplement 2 p. S263-S264
2 p.
 artikel
69 P.2.d.018 Agomelatine differentially modulates neuronal plasticity markers and MAP-2 in the rat PFC, hippocampus and amygdala Ladurelle, N.
 2011
 21 Supplement 2 p. S411-S412
2 p.
 artikel
70 P.4.d.002 Chronic CB2r blockade resulted in anxiolytic action and increased cannabinoid-2 receptor (CB2r), GABAaAlpha2, GABAaGamma2 mRNA levels in cortex and amygdala of mice García-Gutiérrez, M.S.
 2011
 21 Supplement 2 p. S541-S542
2 p.
 artikel
71 P.6.d.008 Decreased cocaine motor sensitisation and self-administration in mice overexpressing cannabinoid CB2 receptors Aracil-Fernández, A.
 2011
 21 Supplement 2 p. S586-S587
2 p.
 artikel
72 P.1.d.014 Executive impairment in the 6-ODHA rat model of Parkinsonism Sosti, M.
 2011
 21 Supplement 2 p. S298-
1 p.
 artikel
73 P.7.d.001 Home visitation programme for detecting, evaluating and treating socially withdrawn youth in Korea Choi, T.Y.
 2011
 21 Supplement 2 p. S607-
1 p.
 artikel
74 P.5.001 Difference in lesions induced by unilateral administration of 6-hydroxydopamine into the left and right substantia nigra pars compacta Ivanova, E.
 2011
 21 Supplement 2 p. S154-
1 p.
 artikel
75 P.6.d.011 Impaired joint attention in cocaine users Preller, K.
 2011
 21 Supplement 2 p. S588-
1 p.
 artikel
76 P.2.d.004 Participation of the NMDA-NO-sGC pathway of the ventral hippocampus in the modulation of depressive-like behaviour in rats Diniz, C.
 2011
 21 Supplement 2 p. S403-S404
2 p.
 artikel
77 P.1.d.017 Role of elevated plus-maze learning in the absence of one trial tolerance in spontaneously hypertensive rats Lopez, G.B.
 2011
 21 Supplement 2 p. S299-S300
2 p.
 artikel
78 P.2.d.001 1,2,3,4-Tetrahydroisoquinoline produces antidepressant-like effects in modified rat forced swimming test: comparison with imipramine Wasik, A.
 2011
 21 Supplement 2 p. S401-S402
2 p.
 artikel
79 P.3.d.003 The cdk5 cofactor p35 is reduced in schizophrenia postmortem brains: downregulation of cdk5/p35/p25 after antipsychotic medication Ramos-Miguel, A.
 2011
 21 Supplement 2 p. S507-S508
2 p.
 artikel
80 P.2.e.032 Anxiety disorder comorbidity in patients with bipolar disorder Toprak, E.
 2011
 21 Supplement 2 p. S436-S437
2 p.
 artikel
81 P.1.e.035 Combined voxel-based morphometry and region of interest methods for studying the hippocampus in Asperger syndrome: preliminary findings Parellada, M.
 2011
 21 Supplement 2 p. S323-S324
2 p.
 artikel
82 P.2.e.022 Does shorter vs. longer stabilisation in patients with bipolar I disorder predict relapse? Vieta, E.
 2011
 21 Supplement 2 p. S430-S431
2 p.
 artikel
83 P.6.e.006 Drug users and antipsychotics: the role of off-label prescription Rossi, P.
 2011
 21 Supplement 2 p. S596-S597
2 p.
 artikel
84 P.6.014 Effect of mitochondrial antioxidant SKQ-1 on the behaviour of albino rats after acute ethanol intoxication Efimova, E.V.
 2011
 21 Supplement 2 p. S167-S168
2 p.
 artikel
85 P.1.e.008 High -resolution regional cerebral blood volume mapping by using pharmacological high-field magnetic resonance imaging Cleppien, D.
 2011
 21 Supplement 2 p. S307-S308
2 p.
 artikel
86 P.3.e.010 Homicide, schizophrenia and alcohol: a systematic review Richard-Devantoy, S.
 2011
 21 Supplement 2 p. S518-
1 p.
 artikel
87 P.2.e.009 Morning serum cortisol during euthymia in bipolar 1 and 2 disorder compared with healthy controls Johansson, A.G.M.
 2011
 21 Supplement 2 p. S422-S423
2 p.
 artikel
88 P.1.022 Epigenetic modifications in transgenic mouse with human polymorphism (Val66Met) of BDNF gene Corna, S.
 2011
 21 Supplement 2 p. S19-S20
2 p.
 artikel
89 P.2.e.008 The impact of brief depressive episodes on the outcome of bipolar and major depressive disorder: a 1-year prospective study Serati, M.
 2011
 21 Supplement 2 p. S422-
1 p.
 artikel
90 P.2.e.005 The McLean–Harvard First Episode Project: two-year functional recovery in 152 first-episode bipolar-I disorder patients Cruz, N.
 2011
 21 Supplement 2 p. S420-
1 p.
 artikel
91 P.3.e.007 Use of valproate for aggressive behaviour in forensic inpatients with schizophrenia Popescu, A.
 2011
 21 Supplement 2 p. S516-
1 p.
 artikel
92 P.1.g.006 A selective blockade of 5-HT7 receptors promotes cognitive flexibility in rats Nikiforuk, A.
 2011
 21 Supplement 2 p. S332-
1 p.
 artikel
93 P.1.g.028 Cognitive effects and Fluoro Jade-C staining in the assessment of 2-vessel occlusion model of brain ischemia in mice Schiavon, A.P.
 2011
 21 Supplement 2 p. S344-S345
2 p.
 artikel
94 P.1.g.009 Cognitive functioning in patients with schizophrenia vs bipolar disorder: an observational study Cerveri, G.
 2011
 21 Supplement 2 p. S333-S334
2 p.
 artikel
95 P.2.g.008 Mapping structural impact of Val66Met BDNF genotype in melancholic depression: influence on time to clinical remission Soria, V.
 2011
 21 Supplement 2 p. S444-S445
2 p.
 artikel
96 P.1.g.023 Paired pulse facilitation as an indicator of short term memory in cold exposed rats Dolu, N.
 2011
 21 Supplement 2 p. S341-S342
2 p.
 artikel
97 P.2.g.011 The level of aggression among psychiatrists Kozmin, A.
 2011
 21 Supplement 2 p. S446-S447
2 p.
 artikel
98 P.1.h.003 Influence of eating attitude on depressive symptoms among high school students in Korea Kim, M.D.
 2011
 21 Supplement 2 p. S350-
1 p.
 artikel
99 P.1.h.006 Study quality and placebo response in randomised controlled trials in schizophrenia conducted 1966–2009 Agid, O.
 2011
 21 Supplement 2 p. S351-S352
2 p.
 artikel
100 P.8.002 Hydrolysis of 1-methyl-5-phenyl-3-acetoxy-7-bromo-1,2-dihydro-3H-1,4-benzodiazepine-2-one with the help of pig liver microsomes Shesterenko, E.A.
 2011
 21 Supplement 2 p. S172-S173
2 p.
 artikel
101 P.1.020 Influence of melatonin on blood flow in cerebral cortex under conditions of global transient ischemia Maslennikov, D.
 2011
 21 Supplement 2 p. S127-
1 p.
 artikel
102 P.4.001 Influence of single and chronic intranasal injections of the arginine-vasopressin fragment Ac-D-MPRG on the ontogeny of the behavioural reactions in white rats Voskresenskaya, O.
 2011
 21 Supplement 2 p. S145-
1 p.
 artikel
103 P.3.017 In vivo measurements of brain serotonergic markers and analysis of drug use profiles among recreational ecstasy and hallucinogen users Erritzoe, D.
 2011
 21 Supplement 2 p. S72-S73
2 p.
 artikel
104 P.1.002 Memory-stimulating effect of dehydroepiandrosterone: involvement of dopaminergic receptor systems Fedotova, J.
 2011
 21 Supplement 2 p. S117-S118
2 p.
 artikel
105 P.2.029 Olanzapine effects on hyperphagia are induced by enhanced histaminergic neurotransmission Revsin, Y.
 2011
 21 Supplement 2 p. S57-S58
2 p.
 artikel
106 P.1.038 PARP, a chromatin structure modulator, attenuates consolidation of fear-associated memories Elharrar, E.
 2011
 21 Supplement 2 p. S31-S32
2 p.
 artikel
107 Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response? Schennach-Wolff, Rebecca
 2011
 21 Supplement 2 p. 370-378
9 p.
 artikel
108 P.1.005 Retinoic acid upregulates reduced cd38 transcription in lymphoblastoid cell lines from patients with autism spectrum disorder Riebold, M.
 2011
 21 Supplement 2 p. S5-S6
2 p.
 artikel
109 P.1.034 Self reported traffic violations and driving errors are associated with markers of the serotonin system Eensoo, D.
 2011
 21 Supplement 2 p. S135-
1 p.
 artikel
110 P.5.010 The behavioural and neurochemical effects of NGF dipeptide fragment GK-2 in MPTP-lesioned C57BL mice Ponomarev, A.V.
 2011
 21 Supplement 2 p. S159-
1 p.
 artikel
111 P.8.007 The biotechnological production of potential neuroprotectants: oligo-3-hydroxybutyrates Bonartsev, A.P.
 2011
 21 Supplement 2 p. S175-S176
2 p.
 artikel
112 P.2.015 The contribution of GABAA receptor alpha subunits in the actions of benzodiazepines using stress-induced hyperthermia in rats Vinkers, C.H.
 2011
 21 Supplement 2 p. S46-S47
2 p.
 artikel
113 P.3.003 The effects of quetiapine on emotional processing Rock, P.L.
 2011
 21 Supplement 2 p. S60-S61
2 p.
 artikel
114 P.4.015 The interlinear effects of the combined injection of afobazol and selective antagonists of serotonin (5-HT) receptors: a behavioural study Narkevich, V.B.
 2011
 21 Supplement 2 p. S152-S153
2 p.
 artikel
115 P.2.001 The presence and clinical implications of comorbid depressive disorder in women with epilepsy Todorova, K.
 2011
 21 Supplement 2 p. S136-S137
2 p.
 artikel
116 P.5.011 Unseen face of polypharmacy in Alzheimer's disease - a focus on drug-drug interactions Vrabie, M.
 2011
 21 Supplement 2 p. S159-S160
2 p.
 artikel
117 S.04.02 Antidepressants modulate human hippocampal neurogenesis by activating the glucocorticoid receptor Anacker, C.
 2011
 21 Supplement 2 p. S188-S189
2 p.
 artikel
118 S.20.03 Control of dopamine release by 5-HT2B receptors in mesoaccumbens versus nigrostriatal pathways Spampinato, U.
 2011
 21 Supplement 2 p. S218-
1 p.
 artikel
119 S.2.02 Cortical and hippocampal regulation of amygdala-dependent emotion Ressler, K.
 2011
 21 Supplement 2 p. S34-S35
2 p.
 artikel
120 Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies Zuddas, Alessandro
 2011
 21 Supplement 2 p. 600-620
21 p.
 artikel
121 S.09.05 fTMS and treatment of psychiatric disorders Sommer, I.
 2011
 21 Supplement 2 p. S201-
1 p.
 artikel
122 S.28.01 Glycine transporters: essential regulators of synaptic transmission Eulenburg, V.
 2011
 21 Supplement 2 p. S230-
1 p.
 artikel
123 S.16.03 Hippocampal volume decrease in depression: what can we learn from animal models? Czéh, B.
 2011
 21 Supplement 2 p. S211-S212
2 p.
 artikel
124 S.27.02 Identification and characterisation of putative ADHD risk genes Lesch, K.P.
 2011
 21 Supplement 2 p. S228-S229
2 p.
 artikel
125 S.14.02 Imaging modalities to determine pathophysiological changes in the brain and the blood–brain barrier Wardlaw, J.
 2011
 21 Supplement 2 p. S207-S208
2 p.
 artikel
126 S.07.02 In vivo measurements of brain serotonergic markers and analysis of drug use profiles among recreational ecstasy and hallucinogen users Erritzoe, D.
 2011
 21 Supplement 2 p. S195-
1 p.
 artikel
127 S.23.05 MDMA and other party drugs: neural and social effects in rodents McGregor, I.
 2011
 21 Supplement 2 p. S223-
1 p.
 artikel
128 S.1.03 Nicotine-opioid interactions: in vitro and in vivo studies Tuominen, R.K.
 2011
 21 Supplement 2 p. S105-S106
2 p.
 artikel
129 S.10.03 PET [11C]raclopride studies of dopamine release in subjects at risk for mood and substance use disorders Leyton, M.
 2011
 21 Supplement 2 p. S202-
1 p.
 artikel
130 S.19.04 The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia Uhlhaas, P.
 2011
 21 Supplement 2 p. S217-
1 p.
 artikel
131 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery Haro, J.M.
 2011
 21 Supplement 2 p. 287-293
7 p.
 artikel
                             131 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland